A Risk Prognostic Signature Basing on Cuproptosis-related Ferroptosis and Immune Genes for Esophageal Squamous Cell Carcinoma Patients

Jun 12, 2025Cell biochemistry and biophysics

A Risk Prediction Signature Using Copper-Linked Cell Death, Iron-Related Cell Death, and Immune Genes for Esophageal Squamous Cell Cancer Patients

AI simplified

Circadian Biology on OpenScience ↗PubMed ↗DOI ↗

Abstract

Thirteen prognostically relevant cuproptosis-associated ferroptosis and immune-related genes were identified, forming a risk score model that predicts overall survival in esophageal squamous cell carcinoma.

The risk score model (FI-CRS) shows robust predictive performance in both the training cohort (n = 179) and independent validation cohort (n = 81).
High-risk patients are associated with significantly reduced overall survival (p < 0.05).
Functional analyses indicate strong links between the risk score and immunoregulatory pathways.
Differences in immune cell infiltration and drug sensitivity were observed between high-risk and low-risk groups.
A prognostic nomogram incorporating clinical features and the risk score may enhance individualized survival prediction.

AI simplified

Esophageal cancer (EC) is a highly aggressive malignancy, with esophageal squamous cell carcinoma (ESCC) accounting for the majority of cases worldwide. Despite advances in treatment, the prognosis for ESCC remains poor, underscoring the urgent need for reliable prognostic biomarkers to guide clinical decision-making. In this study, we constructed a novel prognostic model by integrating cuproptosis-related genes with ferroptosis and immune-associated genes-three critical pathways implicated in tumor progression and immune modulation. Gene expression and clinical data from ESCC patients were obtained from the GSE53625 and TCGA-ESCC cohorts. Ferroptosis- and immune-related genes (FIRGs) were sourced from FerrDb and ImmPort databases, and their association with cuproptosis-related genes was determined via Pearson correlation, yielding a set of cuproptosis-associated FIRGs (FI-CRGs). Thirteen prognostically relevant FI-CRGs were identified through Cox regression analysis and used to develop a risk score model (FI-CRS). The FI-CRS demonstrated robust predictive performance in both the training cohort (GSE53625, n = 179) and the independent validation cohort (TCGA-ESCC, n = 81), where high-risk patients exhibited significantly reduced overall survival (p < 0.05). Functional enrichment analyses (GO and KEGG) revealed strong associations between high FI-CRS and immunoregulatory pathways. Further investigation showed notable differences in immune cell infiltration and drug sensitivity between risk groups. Additionally, a prognostic nomogram incorporating clinical features (age, gender, TNM staging, and FI-CRS) was established to enhance individualized survival prediction. Altogether, this study presents a novel, integrative in silico framework that not only offers promising biomarkers for prognosis but also provides mechanistic insights into ESCC biology, potentially informing future therapeutic strategies.

Full Text

Full text is available at the source.

View full text (PDF) ↗View full text (HTML) ↗

A Risk Prognostic Signature Basing on Cuproptosis-related Ferroptosis and Immune Genes for Esophageal Squamous Cell Carcinoma Patients

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief